Pfizer bets on biotech flu vaccine in $425 mln BioNTech alliance

Pfizer bets on biotech flu vaccine in $425 mln BioNTech alliance


Pfizer has agreed to pay German biotech firm BioNTech up to $425 million in an alliance to develop more effective influenza jabs, the latest among several major pharma companies to bank on a promising new genetic approach. FILE PHOTO: The Pfizer logo is seen at their world headquarters in New York April 28, 2014.



from Biotech News